406 related articles for article (PubMed ID: 18192158)
1. The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy.
Smith EM; Beck SL; Cohen J
Oncol Nurs Forum; 2008 Jan; 35(1):96-102. PubMed ID: 18192158
[TBL] [Abstract][Full Text] [Related]
2. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.
Smith EM; Cohen JA; Pett MA; Beck SL
Cancer Nurs; 2010; 33(3):173-83. PubMed ID: 20357656
[TBL] [Abstract][Full Text] [Related]
3. Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Jann S; Pace A; Plasmati R; Siciliano G; Briani C; Cocito D; Padua L; Ghiglione E; Manicone M; Giussani G;
J Peripher Nerv Syst; 2006 Jun; 11(2):135-41. PubMed ID: 16787511
[TBL] [Abstract][Full Text] [Related]
4. The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.
Cavaletti G; Frigeni B; Lanzani F; Piatti M; Rota S; Briani C; Zara G; Plasmati R; Pastorelli F; Caraceni A; Pace A; Manicone M; Lissoni A; Colombo N; Bianchi G; Zanna C;
J Peripher Nerv Syst; 2007 Sep; 12(3):210-5. PubMed ID: 17868248
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale.
Frigeni B; Piatti M; Lanzani F; Alberti P; Villa P; Zanna C; Ceracchi M; Ildebrando M; Cavaletti G
J Peripher Nerv Syst; 2011 Sep; 16(3):228-36. PubMed ID: 22003937
[TBL] [Abstract][Full Text] [Related]
6. Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool.
Tofthagen CS; McMillan SC; Kip KE
Cancer Nurs; 2011; 34(4):E10-20. PubMed ID: 21242773
[TBL] [Abstract][Full Text] [Related]
7. Clinical challenges: chemotherapy-induced peripheral neuropathy.
Paice JA
Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S8-19. PubMed ID: 19447319
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced peripheral neuropathy: assessment of oncology nurses' knowledge and practice.
Binner M; Ross D; Browner I
Oncol Nurs Forum; 2011 Jul; 38(4):448-54. PubMed ID: 21708535
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.
Cavaletti G; Frigeni B; Lanzani F; Mattavelli L; Susani E; Alberti P; Cortinovis D; Bidoli P
Eur J Cancer; 2010 Feb; 46(3):479-94. PubMed ID: 20045310
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
Wickham R
Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
[TBL] [Abstract][Full Text] [Related]
11. A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Kuroi K; Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Ohsumi S; Watanabe T; Bain S; Hausheer FH
Jpn J Clin Oncol; 2008 Nov; 38(11):748-54. PubMed ID: 18845520
[TBL] [Abstract][Full Text] [Related]
12. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
13. Nursing knowledge, practice patterns, and learning preferences regarding chemotherapy-induced peripheral neuropathy.
Smith EM; Campbell G; Tofthagen C; Kottschade L; Collins ML; Warton C; Ghosh B; Ronis DL; Mallory GA; Visovsky C
Oncol Nurs Forum; 2014 Nov; 41(6):669-79. PubMed ID: 25355022
[TBL] [Abstract][Full Text] [Related]
14. CI-PERINOMS: chemotherapy-induced peripheral neuropathy outcome measures study.
CI-PERINOMS Study Group
J Peripher Nerv Syst; 2009 Jun; 14(2):69-71. PubMed ID: 19691527
[No Abstract] [Full Text] [Related]
15. Patient guide to peripheral neuropathy.
Almadrones LA; Arcot R
Oncol Nurs Forum; 1999 Sep; 26(8):1359-60. PubMed ID: 10497775
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and management of peripheral neuropathy in diabetic patients with cancer.
Visovsky C; Meyer RR; Roller J; Poppas M
Clin J Oncol Nurs; 2008 Apr; 12(2):243-7. PubMed ID: 18390460
[TBL] [Abstract][Full Text] [Related]
17. Background noise: the experience of chemotherapy-induced peripheral neuropathy.
Bakitas MA
Nurs Res; 2007; 56(5):323-31. PubMed ID: 17846553
[TBL] [Abstract][Full Text] [Related]
18. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
19. Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity.
Lanzani F; Mattavelli L; Frigeni B; Rossini F; Cammarota S; Petrò D; Jann S; Cavaletti G
J Peripher Nerv Syst; 2008 Dec; 13(4):267-74. PubMed ID: 19192066
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-Induced Peripheral Neuropathy Assessment Tools: A Systematic Review.
Haryani H; Fetzer SJ; Wu CL; Hsu YY
Oncol Nurs Forum; 2017 May; 44(3):E111-E123. PubMed ID: 28635977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
